IPI Biochemotherapy for Chemonaive Patients With Metastatic Melanoma

NCT01409174 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

19

Enrollment

OTHER

Sponsor class

Stopped Slow accrual, closed in Phase I.

Conditions

Melanoma

Interventions

DRUG: Ipilimumab
DRUG: Temozolomide
DRUG: Cisplatin
DRUG: Interferon Alfa-2b
DRUG: Interleukin-2

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]